Healthtech Startups
16,916 companies tagged Healthtech, with their investors and founders.
2 investors
ArcDia International develops and manufactures in vitro diagnostic solutions for acute infections such as COVID-19, influenza, RSV, and CDI, enabling rapid decentralized testing in hospitals, healthcare centers, and workplaces. The company also offers mariAST for antimicrobial susceptibility testing and mariCloud for real-time epidemiological surveillance.
2 investors
Arcomedlab develops personalized medicine implants and drug-releasing systems to improve patient quality of life. The company designs and manufactures medical devices including orthopedic and dental implants using advanced technologies such as 3D printing.
2 investors
Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.
2 investors
Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control. The company targets patients with acute inflammatory pancreatic disease to prevent progression to systemic illness and organ failure.
2 investors
Arcuro Medical develops all-suture soft-tissue repair technologies for orthopedic surgeons, with its flagship SuperBall® System providing knotless fixation for meniscal and rotator cuff procedures. The company serves sports medicine surgeons globally and holds FDA and CE regulatory clearances.
2 investors
Arena Labs provides digital coaching, educational curriculum, and physiological data tools designed for healthcare professionals. The platform delivers on-demand performance coaching and video-based training from experts to support high-stress medical work.
2 investors
Arey develops a clinical anti-aging haircare system designed to reduce grey hair progression through proprietary supplements and topical formulas. The brand targets consumers seeking science-backed solutions to delay and manage visible hair greying.
2 investors
Argon AI provides an AI-native workspace designed for life sciences, clinical, and commercial teams that automates research workflows, generates insights from medical data, and accelerates drug development processes.
2 investors
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer. It serves clinicians and biopharma partners through its Aventa clinical testing brand and translational science collaborations, using routine FFPE tumor samples to guide diagnosis and therapy selection.
2 investors
ARIZ Precision Medicine develops cancer treatments that combine biological and nanotechnology approaches to target the genetic and epigenetic drivers of cancer, aiming to kill cancer cells while leaving healthy cells undamaged. The company designs targeted drug delivery systems intended to concentrate drugs inside cancer cells.
2 investors
Arkangel connects medical science and artificial intelligence to help healthcare teams make faster clinical decisions and reduce documentation errors. The company builds tools for early risk identification and provides evidence-based medical information to support clinical care delivery.
2 investors
Arkos Health partners with payers to transform provider networks and transition to value-based care models. The company helps payers and providers shift from traditional fee-for-service healthcare to value-based arrangements.
2 investors
ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines. Its technology targets antibacterial and zoonotic diseases to help combat antimicrobial resistance in both livestock and humans.
2 investors
Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
2 investors
Aroa Biosurgery develops soft tissue repair and wound management products based on its AROA ECM extracellular matrix platform, including bioscaffolds for acute and chronic wounds, surgical reconstruction, and hernia repair. Its products, such as Endoform, Myriad Matrix, and Symphony, are used by surgeons and clinicians for soft tissue repair and reconstruction.
2 investors
Arontier is a company that applies artificial intelligence to drug discovery, using proprietary technology and data to develop treatments for incurable and rare diseases. Founded in 2017, it collaborates with companies, experts, and scholars on new medicines and genetic editing.
2 investors
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach. The company targets severe autoimmune and inflammatory disorders for patients with immune-mediated conditions.
2 investors
2 investors
Artiria Medical develops guidewire and access systems for neurovascular procedures, featuring the SmartGUIDE device with a dynamic, controllable tip for navigating tortuous intracerebral anatomy. Its products are aimed at endovascular surgeons and interventionalists treating conditions such as hemorrhagic and ischemic stroke.
2 investors
Ascellus Behavioral Health provides evidence-based behavioral health services and psychological evaluations for workers' compensation claims, addressing psychosocial factors that interfere with recovery following physical injury. The company serves claims adjusters and nurse case managers in the workers' compensation industry.
2 investors
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.
2 investors
Ascension Ventures is a healthcare venture capital fund and innovation catalyst managing over $1 billion in capital that invests in emerging healthcare innovators and technologies. The fund partners with a network of healthcare systems to identify and support solutions addressing complex healthcare challenges.
2 investors
ASG Eye Hospital is a network of eye hospitals in India providing comprehensive ophthalmic care across subspecialties, backed by diagnostic and surgical infrastructure. It also runs fellowship and surgical training programs and partners with public health bodies and state governments, including a collaboration with the Government of Bihar to set up over 200 vision centres.
2 investors